SCHEMBL24323223

SCHEMBL24323223

Cc1cccc(C)c1-c1cc(OC[C@H](N)CC(C)(C)C)nc(NSc2cccc(C(=O)O)c2)n1

nearest known ligand 0.32

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MEN1 O00255 1/20 0.32
ALDH1A1 P00352 1/20 0.32
KMT2A Q03164 1/20 0.32
MRGPRX4 Q96LA9 2/20 0.31
MITF O75030 1/20 0.31
NFKB1 P19838 1/20 0.31
NFKB2 Q00653 1/20 0.31
RELA Q04206 1/20 0.31
PAX8 Q06710 1/20 0.31
KLF5 Q13887 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
APEX1 P27695 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24298126 1.00 SYK (0.32) SYKNPC1RAB9ASMN1; SMN2MEN1
SCHEMBL24298181 0.94 NPC1 (0.33) SYKNPC1RAB9ASMN1; SMN2
SCHEMBL24299042 0.94 NPC1 (0.31) SYKNPC1RAB9ASMN1; SMN2MEN1
SCHEMBL24324763 0.94 NPC1 (0.31) SYKNPC1RAB9ASMN1; SMN2MEN1
SCHEMBL24323572 0.94
SCHEMBL24324602 0.93 ALKBH2 (0.31) NPC1RAB9ASMN1; SMN2MEN1ALDH1A1
SCHEMBL24298904 0.92 LOXL2 (0.31)
SCHEMBL24324181 0.92 SYK (0.31) SYKNPC1RAB9ASMN1; SMN2MEN1
SCHEMBL24298808 0.91 MRGPRX4 (0.31) MRGPRX4
SCHEMBL24323390 0.91 MRGPRX4 (0.37) NPC1RAB9ASMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023196429-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-12 WO disclosed
WO-2022076622-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed